(Total Views: 512)
Posted On: 09/11/2020 12:51:10 PM
Post# of 145903
The most logical reason for taking so long is getting the right patients at the right time and I think the new Patterson Test kits could go hand in hand with determining if someone is a score 4 or above MHRA and FDA. I don’t know what FDA motives are but I think MHRA has been moving very fast ever since they received CD-10 results and maybe taking time to come up with set criteria for moderate population to get prescribed the drug possibly including elderly and people with any underlying condition a 25 year in good health tests positive with mild symptoms isn’t going to be prescribed leronlimab even with EAU not atleast until 100’s Millions of vials. To suggest waiting for severe critical results is what paid bashers try to spread a theory or rumor to for their agenda and make people want to sell today thinking it’s gonna be. Along journey when realistically an EAU could drop before the conference call. No company can give a statement of we are getting approval and than wait for MHRA or FDA to announce. So what is the best possible PR WE CAN GET IS UPDATE ON ONGOING DISCUSSIONS WITH FDA and MHRA no where does it state phase 3 trial required or were waiting for severe results if Safety was in question than maybe small chance that theory would be correct but Leronlimab Safety is not just a homerun it’s a Grandslam deduced SAE 64% they might want to approve on that stat alone never mind the NEWS endpoint met. It’s amazing people don’t see the writing on the wall and very soon there going to be many people telling there family and friends I owned that CYDY stock at $5 and sold it for about $5 and now its at $35 or $75. I won’t be one of them. I bought PENN casino stock at $14 several months ago and sold at $26 thinking nice profit if I had held just couple more months $62 today.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)